NHL (Non-Hodgkin Lymphoma)
3 clinical trials · Condition
◉ Watch NHL (Non-Hodgkin Lymphoma)
| Record | Firm | Date |
|---|---|---|
| JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NCT07603479) | Jecho Biopharmaceuticals Co., Ltd. | 2026-06-25 |
| A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies (NCT06914037) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-31 |
| An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (NCT01929941) | Incyte Corporation | 2013-09-01 |
Track NHL (Non-Hodgkin Lymphoma) automatically
Every clearance here is in the API, with alerts when new ones post.